The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan

E. Rohren

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'The value of 18-FDG PET/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan'. Together they form a unique fingerprint.